Alnylam Pharmaceuticals Market Cap

Alnylam Pharmaceuticals has a market cap or net worth of $41.98 billion as of June 25, 2025. Its market cap has increased by 122.28% in one year.

Market Cap

41.98B

Enterprise Value

42.07B

1-Year Change

122.28%

Ranking

#330

Market Cap Chart

Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $41.98B, an increase of 30,994.25%. That is a compound annual growth rate of 31.30%.

Market Cap History

Date	Market Cap	% Change
Jun 24, 2025	42.38B	39.62%
Dec 31, 2024	30.35B	26.35%
Dec 29, 2023	24.02B	-17.84%
Dec 30, 2022	29.24B	44.16%
Dec 31, 2021	20.28B	34.32%
Dec 31, 2020	15.10B	17.60%
Dec 31, 2019	12.84B	74.32%
Dec 31, 2018	7.37B	-37.48%
Dec 29, 2017	11.78B	266.69%
Dec 30, 2016	3.21B	-59.72%
Dec 31, 2015	7.98B	6.90%
Dec 31, 2014	7.46B	82.96%
Dec 31, 2013	4.08B	326.36%
Dec 31, 2012	956.60M	174.73%
Dec 30, 2011	348.20M	-16.32%
Dec 31, 2010	416.10M	-43.53%
Dec 31, 2009	736.80M	-28.05%
Dec 31, 2008	1.02B	-13.48%
Dec 31, 2007	1.18B	71.64%
Dec 29, 2006	689.60M	94.42%
Dec 30, 2005	354.70M	136.47%
Dec 31, 2004	150.00M	11.11%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	694.40B
Johnson & Johnson	365.99B
AbbVie	327.14B
Novo Nordisk	309.67B
UnitedHealth Group	274.97B
Abbott Laboratories	238.69B
Novartis AG	229.25B
AstraZeneca	218.15B

Market Cap Rankings